Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

JPMorgan Chase & Co (NY: JPM )

253.76 +1.41 (+0.56%)
Streaming Delayed Price Updated: 11:34 AM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about JPMorgan Chase & Co

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Focusing on Neuroscience, Oncology, and Ophthalmology Pipelines 
Via TheNewswire.com
JPMorganChase Declares Preferred Stock Dividends
From JPMorgan Chase & Co.
Via Business Wire
InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Positioning with Dynamic Approach to Sports Ownership
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal DepressionMIAMI - Jan. 2, 2025 - PRLog -- Developing NRX-101, an FDA-Designated... 
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
$NRXP: Completion of NDA Filing Expected in First Quarter of 2025MIAMI - Dec. 30, 2024 - PRLog -- Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal... 
Via PRLog
Exposures Product Safety
JPMorganChase Reports Fourth-Quarter and Full-Year 2024 Financial Results
From JPMorgan Chase & Co.
Via Business Wire
Ammunition Appoints Kate Grafton as VP of Client Engagement
Atlanta, Georgia--(Newsfile Corp. - January 14, 2025) - Ammunition, an Atlanta-based full-funnel advertising agency, has appointed Kate Grafton as Vice... 
Via Newsfile
JPMorganChase Announces New Responsibilities for Senior Leaders
From JPMorgan Chase & Co.
Via Business Wire
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside
Via AB Newswire
Topics Regulatory Compliance
Exposures Legal Regulatory
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other... 
Via Newsfile
Exposures Product Safety
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present Broad-Spectrum Antiviral Innovations at Biotech Showcase 2025
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
Salt Lake City, Utah--(Newsfile Corp. - January 9, 2025) - BioUtah, the trade association,... 
Via Newsfile
JPMorganChase, Axios, and U.S. Conference of Mayors Partner to Highlight and Scale Solutions in Local Communities
From JPMorgan Chase & Co.
Via Business Wire
SUNRATE Expands Beyond Global Payments in 2025 by Introducing New Treasury Solutions
SINGAPORE - Media OutReach Newswire - 9 January 2025 - SUNRATE, the global payment and treasury management platform, kickstarts the new year by introducing... 
Via MediaOutReach
JPMorganChase Survey: Businesses Ring in the New Year with Renewed Optimism
From JPMorgan Chase & Co.
Via Business Wire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025
ATLANTA, GA - January 6, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced... 
Via TheNewswire.com
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
Via Investor Brand Network
OS Therapies Partners With B2i Digital to Engage With Biotech Investors Online
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
J.P. Morgan Wealth Management Ranks #1 in J.D. Power Digital Experience Study
From JPMorgan Chase & Co.
Via Business Wire
JPMorganChase to Host Fourth-Quarter and Full-Year 2024 Earnings Call
From JPMorgan Chase & Co.
Via Business Wire
Chase Freedom® Celebrates 15 Years of Rotating Cash Back Categories, Kicking Off 2025 With: Norwegian Cruise Lines, Grocery Stores, Fitness Clubs and Self-Care Services
From Chase Freedom
Via Business Wire
JPMorganChase Declares Preferred Stock Dividends
From JPMorgan Chase & Co.
Via Business Wire
Brera Holdings PLC (NASDAQ: BREA) SEC Filing Reveals JPMorgan Chase’s Ownership of Ordinary Shares
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
JPMorganChase Elects Michele G. Buck to its Board of Directors
From JPMorgan Chase & Co.
Via Business Wire
Busting the top 5 myths about sustainable investing
Investors who think about aligning their portfolios with sustainable values can be put off by some of the information they have run across about the practice. 
Via Equities.com
PricingDirect and Aumni Partner to Deliver Independent Valuations for Private Equity Securities
From J.P. Morgan Chase & Co.
Via Business Wire
JPMorganChase Declares Common Stock Dividend
From JPMorgan Chase & Co.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.